BACKGROUND: In the present study, we sought to determine whether opening a persistently occluded infarct-related artery (IRA) by percutaneous coronary intervention (PCI) in patients beyond the acute phase of myocardial infarction (MI) improves patency and indices of left ventricular (LV) size and function. METHODS AND RESULTS: Between May 2000 and July 2005, 381 patients with an occluded native IRA 3 to 28 days after MI (median 10 days) were randomized to PCI with stenting (PCI) or optimal medical therapy alone. Repeat coronary and LV angiography was performed 1 year after randomization (n=332, 87%). Coprimary end points were IRA patency and change in LV ejection fraction. Secondary end points included change in LV end-systolic and end-diastolic volume indices and wall motion. PCI was successful in 92%. At 1 year, 83% of PCI versus 25% of medical therapy-only patients had a patent IRA (P<0.001). LV ejection fraction increased significantly (P<0.001) in both groups, with no between-group difference: PCI 4.2+/-8.9 (n=150) versus medical therapy 3.5+/-8.2 (n=136; P=0.47). Median change (interquartile range) in LV end-systolic volume index was -0.5 (-9.3 to 5.0) versus 1.0 (-5.7 to 7.3) mL/m2 (P=0.10), whereas median change (interquartile range) in LV end-diastolic volume index was 3.2 (-8.2 to 13.3) versus 5.3 (-4.6 to 23.2) mL/m2 (P=0.07) in the PCI (n=86) and medical therapy-only (n=76) groups, respectively. CONCLUSIONS: PCI with stenting of a persistently occluded IRA in the subacute phase after MI effectively maintains long-term patency but has no effect on LV ejection fraction. On the basis of these findings and the lack of clinical benefit in the main Occluded Artery Trial, routine PCI is not recommended for stable patients with a persistently occluded IRA after MI.
RCT Entities:
BACKGROUND: In the present study, we sought to determine whether opening a persistently occluded infarct-related artery (IRA) by percutaneous coronary intervention (PCI) in patients beyond the acute phase of myocardial infarction (MI) improves patency and indices of left ventricular (LV) size and function. METHODS AND RESULTS: Between May 2000 and July 2005, 381 patients with an occluded native IRA 3 to 28 days after MI (median 10 days) were randomized to PCI with stenting (PCI) or optimal medical therapy alone. Repeat coronary and LV angiography was performed 1 year after randomization (n=332, 87%). Coprimary end points were IRA patency and change in LV ejection fraction. Secondary end points included change in LV end-systolic and end-diastolic volume indices and wall motion. PCI was successful in 92%. At 1 year, 83% of PCI versus 25% of medical therapy-only patients had a patent IRA (P<0.001). LV ejection fraction increased significantly (P<0.001) in both groups, with no between-group difference: PCI 4.2+/-8.9 (n=150) versus medical therapy 3.5+/-8.2 (n=136; P=0.47). Median change (interquartile range) in LV end-systolic volume index was -0.5 (-9.3 to 5.0) versus 1.0 (-5.7 to 7.3) mL/m2 (P=0.10), whereas median change (interquartile range) in LV end-diastolic volume index was 3.2 (-8.2 to 13.3) versus 5.3 (-4.6 to 23.2) mL/m2 (P=0.07) in the PCI (n=86) and medical therapy-only (n=76) groups, respectively. CONCLUSIONS: PCI with stenting of a persistently occluded IRA in the subacute phase after MI effectively maintains long-term patency but has no effect on LV ejection fraction. On the basis of these findings and the lack of clinical benefit in the main Occluded Artery Trial, routine PCI is not recommended for stable patients with a persistently occluded IRA after MI.
Authors: Zaheer R Yousef; Simon R Redwood; Clifford A Bucknall; Alfred N Sulke; Michael S Marber Journal: J Am Coll Cardiol Date: 2002-09-04 Impact factor: 24.094
Authors: Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White Journal: Am Heart J Date: 2005-10 Impact factor: 4.749
Authors: V Dzavik; R G Carere; G B Mancini; E A Cohen; D Catellier; T E Anderson; G Barbeau; C Lazzam; L M Title; P B Berger; M Labinaz; K K Teo; C E Buller Journal: Am Heart J Date: 2001-08 Impact factor: 4.749
Authors: S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox Journal: Lancet Date: 2001-08-18 Impact factor: 79.321
Authors: Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud Journal: N Engl J Med Date: 2006-11-14 Impact factor: 91.245
Authors: J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook Journal: Circulation Date: 1987-07 Impact factor: 29.690
Authors: Harmony R Reynolds; Sandra A Forman; Jacqueline E Tamis-Holland; Philippe Gabriel Steg; Daniel B Mark; Camille A Pearte; Antonio C Carvalho; George Sopko; Li Liu; Gervasio A Lamas; Mariusz Kruk; Krystyna Loboz-Grudzien; Witold Ruzyllo; Judith S Hochman Journal: Am Heart J Date: 2012-03 Impact factor: 4.749
Authors: Xavier Freixa; Vladimír Džavík; Sandra A Forman; James M Rankin; Christopher E Buller; Warren J Cantor; Witold Ruzyllo; Harmony R Reynolds; Gervasio A Lamas; Judith S Hochman Journal: Am Heart J Date: 2012-06 Impact factor: 4.749
Authors: Irene M Lang; Sandra A Forman; Aldo P Maggioni; Witold Ruzyllo; Jean Renkin; Carlos Vozzi; P Gabriel Steg; Jose-Maria Hernandez-Garcia; Krzysztof Zmudka; Manuel Jimenez-Navarro; George Sopko; Gervasio A Lamas; Judith S Hochman Journal: EuroIntervention Date: 2009-11 Impact factor: 6.534
Authors: Eric J Rashba; Gervasio A Lamas; Jean-Philippe Couderc; Sharri M Hollist; Vladimir Dzavik; Witold Ruzyllo; Viliam Fridrich; Christopher E Buller; Sandra A Forman; Joseph A Kufera; Antonio C Carvalho; Judith S Hochman Journal: Circulation Date: 2009-02-02 Impact factor: 29.690
Authors: Christopher E Buller; Jamie M Rankin; Ronald G Carere; Pawel E Buszman; Matthias E Pfisterer; Vladimir Dzavik; Boban Thomas; Sandra Forman; Witold Ruzyllo; G B John Mancini; Lampros K Michalis; Pedro F Abreu; Gervasio A Lamas; Judith S Hochman Journal: Am Heart J Date: 2009-09 Impact factor: 4.749
Authors: Venu Menon; Witold Ruzyllo; Antonio C Carvalho; Jose Marconi Almeida de Sousa; Sandra A Forman; Krystyna Jaworska; Gervasio A Lamas; Marek Roik; Christophe Thuaire; Yoav Turgeman; Judith S Hochman Journal: Am J Cardiol Date: 2013-01-22 Impact factor: 2.778